Logo 1 Logo 2

Clinical Trial Details

Trial ID: L4461
Source ID: NCT00766441
Associated Drug: Sitagliptin
Title: Sitagliptin Versus Sulphonylurea in Type 2 Diabetes During Ramadan
Acronym:
Status: TERMINATED
Study Results: NO
Results:
Conditions: Diabetes|Hypoglycemia
Interventions: DRUG: Sitagliptin|DRUG: sulphonylurea
Outcome Measures: Primary: Occurrence of hypoglycemia, 4 weeks during Ramadan | Secondary: Body weight, fasting blood sugar, HbA1c, triglycerides, total cholesterol, LDL-C, HDL-C. CGMS to define glycaemic excursions, 4 weeks during Ramadan
Sponsor/Collaborators: Sponsor: University of Manchester
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE4
Enrollment: 22
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2008-08
Completion Date: 2009-10
Results First Posted:
Last Update Posted: 2010-01-12
Locations: Wellcome Trust Clinical Research Facility, Manchester, M13 9NT, United Kingdom
URL: https://clinicaltrials.gov/show/NCT00766441